Mumbai, Dec. 4 -- SMS Pharmaceuticals has received revision in credit ratings from CARE Ratings as under:

Long term bank facilities (Rs 350.87 crore) - CARE A; Positive (reaffirmed, outlook revised from Stable)

Short term bank facilities (Rs 52.83 crore) - CARE A1 (upgraded from CARE A2+)

Published by HT Digital Content Services with permission from Capital Market....